Ascendis Pharma A/S (ASND) vs Roivant Sciences (ROIV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Roivant Sciences (ROIV) has outperformed Ascendis Pharma A/S (ASND) over the past year, gaining 113.4% versus a gain of 6.0%. Over five years, ROIV leads with a +477.2% price change compared with +39.2% for ASND. Roivant Sciences is the larger company by market cap ($24.71 billion vs $14.65 billion), about 1.7 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ASND | ROIV |
|---|---|---|
| Share price | $222.69 | $34.21 |
| Market cap | $14.65B | $24.71B |
| 1-day change | -2.50% | -1.55% |
| YTD return | +4.43% | +57.65% |
| 1-year return | +5.98% | +113.41% |
| 5-year return | +39.19% | +477.24% |
| P/E ratio (TTM) | 17.06 | — |
| Forward P/E | 20.68 | — |
| EPS (TTM) | $13.05 | $-0.53 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $8.26M |
| Revenue growth (YoY) | — | -71.57% |
| Net income (latest FY) | — | $-299.77M |
| Operating margin | — | -6235.69% |
| Net margin | — | -3629.19% |
| 52-week high | $282.15 | $42.50 |
| 52-week low | $186.05 | $15.90 |
| Distance from 52-week high | -21.07% | -19.51% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +37.34% | +40.54% |
| Average volume | 662.79K | 7.04M |
| Shares outstanding | 65.80M | 722.32M |
| Employees | 1,189 | 721 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ROIV has outperformed ASND by 107.4 percentage points over the past year.
About Ascendis Pharma A/S
ASND stock →Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism.
Health Care · Biotechnology: Pharmaceutical Preparations · 1,189 employees
About Roivant Sciences
ROIV stock →Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 721 employees
ASND vs ROIV FAQ
Which is bigger, Ascendis Pharma A/S or Roivant Sciences?
Roivant Sciences (ROIV) is larger, with a market capitalization of $24.71B compared with $14.65B for Ascendis Pharma A/S (ASND).
Which stock has performed better over the past year, ASND or ROIV?
ROIV returned +113.41% over the past 12 months, compared with +5.98% for ASND (price return, excluding dividends). Past performance does not predict future results.
Are Ascendis Pharma A/S and Roivant Sciences in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.